A calculator to predict benefit from adjuvant transarterial chemoembolization for hepatocellular carcinoma
by First Hospital of Jilin UniversityVisual Abstract. Credit: Wei-Yue Chen, Jian-Song Ji, Tian Yang, et al.Hepatocellular carcinoma (HCC) is the most commonly diagnosed cancer of the liver and the fou
Updated on: February 20,2024
20

A calculator to predict benefit from adjuvant transarterial chemoembolization for hepatocellular carcinoma
by First Hospital of Jilin UniversityVisual Abstract. Credit: Wei-Yue Chen, Jian-Song Ji, Tian Yang, et al.Hepatocellular carcinoma (HCC) is the most commonly diagnosed cancer of the liver and the fou
Updated on:February 20,2024
20
